Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 17142799)

1.

3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro.

Zhang W, Shin EJ, Wang T, Lee PH, Pang H, Wie MB, Kim WK, Kim SJ, Huang WH, Wang Y, Zhang W, Hong JS, Kim HC.

FASEB J. 2006 Dec;20(14):2496-511.

2.
3.

Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.

Dugan LL, Tian L, Quick KL, Hardt JI, Karimi M, Brown C, Loftin S, Flores H, Moerlein SM, Polich J, Tabbal SD, Mink JW, Perlmutter JS.

Ann Neurol. 2014 Sep;76(3):393-402. doi: 10.1002/ana.24220. Epub 2014 Jul 22.

PMID:
25043598
4.

The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model.

Fernández-Suárez D, Celorrio M, Riezu-Boj JI, Ugarte A, Pacheco R, González H, Oyarzabal J, Hillard CJ, Franco R, Aymerich MS.

Neurobiol Aging. 2014 Nov;35(11):2603-16. doi: 10.1016/j.neurobiolaging.2014.05.021. Epub 2014 May 28.

PMID:
24973119
5.

PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease.

Ahn EH, Kim DW, Shin MJ, Kim HR, Kim SM, Woo SJ, Eom SA, Jo HS, Kim DS, Cho SW, Park J, Eum WS, Choi SY.

Biochim Biophys Acta. 2014 Jun;1840(6):1686-700. doi: 10.1016/j.bbagen.2014.01.004. Epub 2014 Jan 8.

PMID:
24412329
6.

Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.

Kim HG, Park G, Piao Y, Kang MS, Pak YK, Hong SP, Oh MS.

Food Chem Toxicol. 2014 Mar;65:293-300. doi: 10.1016/j.fct.2013.12.037. Epub 2014 Jan 2.

PMID:
24389454
7.

Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.

Guo B, Xu D, Duan H, Du J, Zhang Z, Lee SM, Wang Y.

Biol Pharm Bull. 2014;37(2):274-85. Epub 2013 Dec 3.

8.

GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.

Kosloski LM, Kosmacek EA, Olson KE, Mosley RL, Gendelman HE.

J Neuroimmunol. 2013 Dec 15;265(1-2):1-10. doi: 10.1016/j.jneuroim.2013.10.009. Epub 2013 Oct 29.

9.

Dangguijakyak-San Protects against 1-Methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-Induced Neuronal Damage via Anti-Inflammatory Action.

Hwang DS, Kim HG, Jang JB, Oh MS.

Evid Based Complement Alternat Med. 2013;2013:976270. doi: 10.1155/2013/976270. Epub 2013 Aug 31.

10.

Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice.

Zhu G, Wang X, Wu S, Li X, Li Q.

Phytother Res. 2014 Feb;28(2):179-86. doi: 10.1002/ptr.4975. Epub 2013 Mar 20.

PMID:
23512787
11.

Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model.

Philippens IH, Wubben JA, Finsen B, 't Hart BA.

J Neuroimmune Pharmacol. 2013 Jun;8(3):715-26. doi: 10.1007/s11481-013-9450-z. Epub 2013 Mar 17.

PMID:
23504289
12.

Da-Bu-Yin-Wan and Qian-Zheng-San, two traditional Chinese herbal formulas, up-regulate the expression of mitochondrial subunit NADH dehydrogenase 1 synergistically in the mice model of Parkinson's disease.

Zhang Y, Sun HM, He X, Wang YY, Gao YS, Wu HX, Xu H, Gong XG, Guo ZY.

J Ethnopharmacol. 2013 Mar 7;146(1):363-71. doi: 10.1016/j.jep.2013.01.005. Epub 2013 Jan 21.

PMID:
23347961
13.

Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's disease.

De Miranda BR, Miller JA, Hansen RJ, Lunghofer PJ, Safe S, Gustafson DL, Colagiovanni D, Tjalkens RB.

J Pharmacol Exp Ther. 2013 Apr;345(1):125-38. doi: 10.1124/jpet.112.201558. Epub 2013 Jan 14.

14.

S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway.

Sathe K, Maetzler W, Lang JD, Mounsey RB, Fleckenstein C, Martin HL, Schulte C, Mustafa S, Synofzik M, Vukovic Z, Itohara S, Berg D, Teismann P.

Brain. 2012 Nov;135(Pt 11):3336-47. doi: 10.1093/brain/aws250.

15.

Senescence marker protein 30 deficiency increases Parkinson's pathology by impairing astrocyte activation.

Kim HS, Son TG, Park HR, Lee Y, Jung Y, Ishigami A, Lee J.

Neurobiol Aging. 2013 Apr;34(4):1177-83. doi: 10.1016/j.neurobiolaging.2012.10.008. Epub 2012 Oct 31.

PMID:
23122412
16.

Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease.

De Jesús-Cortés H, Xu P, Drawbridge J, Estill SJ, Huntington P, Tran S, Britt J, Tesla R, Morlock L, Naidoo J, Melito LM, Wang G, Williams NS, Ready JM, McKnight SL, Pieper AA.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17010-5. doi: 10.1073/pnas.1213956109. Epub 2012 Oct 1.

17.

Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model.

Banerjee A, Patil S, Pawar MY, Gullapalli S, Gupta PK, Gandhi MN, Bhateja DK, Bajpai M, Sangana RR, Gudi GS, Khairatkar-Joshi N, Gharat LA.

Bioorg Med Chem Lett. 2012 Oct 1;22(19):6286-91. doi: 10.1016/j.bmcl.2012.07.077. Epub 2012 Aug 8.

PMID:
22944118
18.

Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.

Esposito E, Impellizzeri D, Mazzon E, Paterniti I, Cuzzocrea S.

PLoS One. 2012;7(8):e41880. doi: 10.1371/journal.pone.0041880. Epub 2012 Aug 17.

19.

Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.

Yao L, Li W, She H, Dou J, Jia L, He Y, Yang Q, Zhu J, Cápiro NL, Walker DI, Pennell KD, Pang Y, Liu Y, Han Y, Mao Z.

J Biol Chem. 2012 Oct 5;287(41):34246-55. doi: 10.1074/jbc.M112.367540. Epub 2012 Aug 13.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk